[1]
|
S. P. McDonald and G. R. Russ, “Burden of End-Stage Renal Disease among Indigenous Peoples in Australia and New Zealand,” Kidney International, Vol. 63, 2003, pp. S123-S127. doi:10.1046/j.1523-1755.63.s83.26.x
|
[2]
|
S. P. McDonald and G. R. Russ, “Current Incidence, Treatment Patterns and Outcome of End-Stage Renal Disease among Indigenous Groups in Australia and New Zealand,” Nephrology, Vol. 8, No. 1, 2003, pp. 42-48.
doi:10.1046/j.1440-1797.2003.00131.x
|
[3]
|
K. E. Yeates, A. Cass, T. D. Sequist, S. P. McDonald, M. J. Jardine, L. Trpeski, et al., “Indigenous People in Australia, Canada, New Zealand and the United States Are Less Likely to Receive Renal Transplantation,” Kidney International, Vol. 76, No. 6, 2009, pp. 659-664.
doi:10.1038/ki.2009.236
|
[4]
|
B. A. Pussell, A. Bendorf and I. H. Kerridge, “Access to the Kidney Transplant Waiting List: A Time for Reflection,” Internal Medicine Journal, Vol. 42, No. 4, 2012, pp. 360-363. doi:10.1111/j.1445-5994.2012.02730.x
|
[5]
|
S. McDonald, “Indigenous Transplant Outcomes in Australia: What the ANZDATA Registry Tells Us,” Nephrology, Vol. 9, No. 4, 2004, pp. S138-S143.
doi:10.1111/j.1440-1797.2004.00350.x
|
[6]
|
N. M. Rogers, P. D. Lawton and M. D. Jose, “Kidney Transplant Outcomes in the Indigenous Population in the Northern Territory of Australia,” Transplantation, Vol. 82, No. 7, 2006, pp. 882-886.
doi:10.1097/01.tp.0000232439.88527.49
|
[7]
|
N. M. Rogers, P. D. Lawton and M. D. Jose, “Indigenous Australians and Living Kidney Donation,” The New England Journal of Medicine, Vol. 361, No. 15, 2009, pp. 1513-1516. doi:10.1056/NEJMc0905777
|
[8]
|
J. S. Davis, B. J. Currie, D. A. Fisher, S. E. Huffam, N. M. Anstey, R. N. Price,1 V. L. Krause, N. Zweck, P. D. Lawton, P. L. Snelling and S. Selva-Nayagam, “Prevention of Opportunistic Infections in Immunosuppressed Patients in the Tropical Top End of the Northern Territory of Australia,” Communicable Diseases Intelligence, Vol. 27, No. 4, 2003, pp. 526-532.
|
[9]
|
N. M. Anstey, I. Bastian, H. Dunckley and B. J. Currie, “Systemic Lupus Erythematosus (SLE): Different Prevalences in Different Populations of Australian Aborigines,” Australian and New Zealand Journal of Medicine, Vol. 25, No. 6, 1995, pp. 736-737.
doi:10.1111/j.1445-5994.1995.tb02863.x
|
[10]
|
N. M. Anstey, I. Bastian, H. Dunckley and B. J. Currie, “Systemic Lupus Erythematosus in Australian Aborigines: High Prevalence, Morbidity and Mortality,” Australian and New Zealand Journal of Medicine, Vol. 23, No. 1993, pp. 646-651. doi:10.1111/j.1445-5994.1993.tb04720.x
|
[11]
|
D. M. Grennan and D. Bossingham, “Systemic Lupus Erythematosus (SLE): Different Prevalences in Different Po- pulations of Australian Aboriginals,” Australian and New Zealand Journal of Medicine, Vol. 25, No. 2, 1995, pp. 182-183. doi:10.1111/j.1445-5994.1995.tb02843.x
|
[12]
|
K. Andreasyan and W. E. Hoy, “Patterns of Mortality in Indigenous Adults in the Northern Territory, 1998-2003: Are People Living in More Remote Areas Worse off?” The Medical Journal of Australia, Vol. 190, No. 6, 2009, pp. 307-311.
|
[13]
|
K. Andreasyan and W. E. Hoy, “Recent Patterns in Chronic Disease Mortality in Remote Living Indigenous Australians,” BMC Public Health, Vol. 10, No. 1, 2010, pp. 483-487. doi:10.1186/1471-2458-10-483
|
[14]
|
N. M. Rogers, P. D. Lawton and M. D. Jose, “Plasma Cell Infiltrates and Renal Allograft Outcomes in Indigenous and Non-Indigenous People of the Northern Territory of Australia,” Nephrology, Vol. 16, No. 8, 2011, pp. 777-783.
|
[15]
|
K. Anderson, A. Cass, J. Cunningham, P. Snelling, J. Devitt and C. Preece, “The Use of Psychosocial Criteria in Australian Patient Selection Guidelines for Kidney Transplantation,” Social Science & Medicine, Vol. 64, No. 10, 2007, pp. 2107-2114.
|
[16]
|
K. Anderson, J. Devitt, J. Cunningham, C. Preece, M. Jardine and A. Cass, “If You Can’t Comply with Dialysis, How Do You Expect Me to Trust You with Transplantation? Australian Nephrologists’ Views on Indigenous Australians’ ‘Non-Compliance’ and Their Suitability for Kidney Transplantation,” International Journal for Equity in Health, Vol. 11, 2012, p. 21.
doi:10.1186/1475-9276-11-21
|
[17]
|
A. Cass, J. Cunningham, K. Anderson, P. Snelling, S. A. M. Colman, J. Devitt, et al., “Decision-Making about Suitability for Kidney Transplantation: Results of a National Survey of Australian Nephrologists,” Nephrology, Vol. 12, No. 3, 2007, pp. 299-304.
doi:10.1111/j.1440-1797.2007.00784.x
|
[18]
|
A. Cass, J. Cunningham, P. Snelling, Z. Wang and W. Hoy, “Renal Transplantation for Indigenous Australians: Identifying the Barriers to Equitable Access,” Ethnicity & Health, Vol. 8, No. 2, 2003, pp. 111-119.
doi:10.1080/13557850303562
|
[19]
|
A. Cass, J. Devitt, C. Preece, J. Cunningham, K. Anderson, P. Snelling, et al., “Barriers to Access by Indigenous Australians to Kidney Transplantation: The IMPAKT Study,” Nephrology, Vol. 9, Suppl. 4, 2004, pp. S144-S146. doi:10.1111/j.1440-1797.2004.00352.x
|
[20]
|
J. Devitt, A. Cass, J. Cunningham, C. Preece, K. Anderson and P. Snelling, “Study Protocol—Improving Access to Kidney Transplants (IMPAKT): A Detailed Account of A Qualitative Study Investigating Barriers to Transplant for Australian Indigenous People with End-Stage Kidney Disease,” BMC Health Services Research, Vol. 8, No. 1, 2008, pp. 24-31. doi:10.1186/1472-6963-8-31
|